Bumper Offer - Urjas oil Just @ Rs. 1
Metosartan CH 50 Tablet ER is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Metosartan CH 50 Tablet ER is used -
Severe
Moderate
Mild
Common
Is the use of Metosartan CH 50 Tablet ER safe for pregnant women?
Metosartan CH shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Metosartan CH 50 Tablet ER safe during breastfeeding?
Side effects of Metosartan CH for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Metosartan CH 50 Tablet ER on the Kidneys?
Metosartan CH does not damage the kidneys.
What is the effect of Metosartan CH 50 Tablet ER on the Liver?
Side effects of Metosartan CH rarely affect the liver.
What is the effect of Metosartan CH 50 Tablet ER on the Heart?
Metosartan CH has very mild side effects on the heart.
Metosartan CH 50 Tablet ER should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Metosartan CH 50 Tablet ER unless your doctor advises you to do so -
Is this Metosartan CH 50 Tablet ER habit forming or addictive?
No, you will not get addicted to Metosartan CH 50 Tablet ER.
Interaction between Food and Metosartan CH 50 Tablet ER
Eating certain foods may increase the time it takes Metosartan CH 50 Tablet ER to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Metosartan CH 50 Tablet ER
Consult your doctor before consuming alcohol while taking Metosartan CH 50 Tablet ER as it can have severe side effects.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
